Skip to content
Screener

Similar metrics at other companies

Veradermics logo
MANER&D
$20.93M+82.8%
Polaryx Therapeutics, Inc. logo
PLYXR&D
$679K-85.6%
Schering-Plough logo
SGPR&D
$8.54M+41.1%
Deere & Company logo
DER&D
$583M+6.2%
Roblox logo
RBLXR&D
$422M+12.8%
Salesforce logo
CRMR&D
$1.63B+11.4%

Other financials

Income statement

See full
Revenue$330.4M+123%
Gross profit$157.9M+128%
Operating income$68.3M+1,220%
Net income$57.4M+1,846%
EPS (diluted)$1.07+1,883%

Balance sheet

See full
Cash & equivalents$240.5M+354%
Total debt$38.1M+4.9%
Total equity$912.0M+8.9%
Total assets$1.3B+17.3%

Cash flow

See full
Operating cash flow$45.2M+626%
CapEx$4.3M+105%
Free cash flow$40.9M+890%

Valuation

See full
Market cap$4.91B+190%
Enterprise value$4.71B+181%
P/E42.4×
P/S5.2×+2.6×

Profitability

See full
Gross margin48.2%+5.0pp
Operating margin-0.6%-0.3pp
Net margin12.2%
FCF margin11.1%+6.0pp

Returns & leverage

See full
Return on equity13.2%
Debt / equity0.0×
Current ratio3.4×-1.5×

Where this comes from

Reported directly by Kulicke & Soffa Industries in its filing.

Tagged under the XBRL concept klic:ResearchAndDevelopmentExpenseIncludingImpairmentChargesAndGainRelatingToCessationOfBusiness.

The source filing: Kulicke & Soffa Industries’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 8:51 AM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q3 2026
Accession
0000056978-26-000032
(in thousands)Three months ended July 4, 2026 / Reportable segments / Ball Bonding EquipmentThree months ended July 4, 2026 / Reportable segments / Wedge Bonding EquipmentThree months ended July 4, 2026 / Reportable segments / Advanced SolutionsThree months ended July 4, 2026 / Reportable segments / APSThree months ended July 4, 2026 / Reconciling items / All OthersThree months ended July 4, 2026 / Reconciling items / Unallocated Corporate ExpensesThree months ended July 4, 2026 / Total Company
Net Revenue$226,068$25,777$29,415$35,772$13,377$330,409
Cost of sales111,46214,78619,20417,5229,45630172,460
Selling, general and administrative9,6002,5914,7653,3392,10023,37445,769
Research and development11,7996,91817,9993,2102,2651,72343,914
Total operating expenses21,3999,50922,7646,5494,36525,09789,683
Income / (Loss) from operations$93,207$1,482$(12,553)$11,701$(444)$(25,127)$68,266

Item 1. – FINANCIAL STATEMENTS

FAQ

What is Kulicke & Soffa Industries's APS — R&D?
Kulicke & Soffa Industries (KLIC) reported APS — R&D of $3.21M in Q2 2026.
How has Kulicke & Soffa Industries's APS — R&D changed year-over-year?
Kulicke & Soffa Industries's APS — R&D increased by 38.1% year-over-year, from $2.33M to $3.21M.
What is the long-term trend for Kulicke & Soffa Industries's APS — R&D?
Over 2 years (2023 to 2025), Kulicke & Soffa Industries's APS — R&D has grown at a -9.9% compound annual growth rate (CAGR), from $22.42M to $18.19M.
What does APS — R&D mean?
Represents expenditures dedicated to the innovation, enhancement, and technical support of aftermarket offerings and service technologies. This investment is crucial for maintaining a competitive edge in service delivery and ensuring the longevity of the company's installed equipment base. It reflects the company's commitment to evolving its service capabilities alongside technological advancements.

Ask your AI about Kulicke & Soffa Industries's aps — r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude